Los Angeles Capital Management
UTMD icon

Los Angeles Capital Management’s Utah Medical Products UTMD Stock Holding History

Los Angeles Capital Management’s Portfolio UTMD Stock Details UTMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-11,685
Closed -$665K – 1546
2025
Q2 		$665K Sell
11,685
-9,243
-44% -$503K ﹤0.01% 777
2025
Q1 		$1.17M Sell
20,928
-2,750
-12% -$165K 0.01% 525
2024
Q4 		$1.46M Sell
23,678
-6,875
-23% -$444K 0.01% 515
2024
Q3 		$2.04M Sell
30,553
-2,730
-8% -$185K 0.01% 455
2024
Q2 		$2.22M Buy
33,283
+20,197
+154% +$1.37M 0.01% 429
2024
Q1 		$931K Buy
13,086
+7,320
+127% +$549K ﹤0.01% 717
2023
Q4 		$486K Hold
5,766
– – ﹤0.01% 879
2023
Q3 		$496K Buy
5,766
+53
+0.9% +$4.89K ﹤0.01% 826
2023
Q2 		$532K Buy
5,713
+451
+9% +$42.5K ﹤0.01% 837
2023
Q1 		$499K Sell
5,262
-275
-5% -$25.3K ﹤0.01% 854
2022
Q4 		$557K Hold
5,537
– – ﹤0.01% 865
2022
Q3 		$472K Hold
5,537
– – ﹤0.01% 941
2022
Q2 		$476K Buy
5,537
+1,849
+50% +$158K ﹤0.01% 984
2022
Q1 		$331K Hold
3,688
– – ﹤0.01% 1207
2021
Q4 		$369K Hold
3,688
– – ﹤0.01% 1151
2021
Q3 		$342K Sell
3,688
-450
-11% -$39.8K ﹤0.01% 1245
2021
Q2 		$352K Hold
4,138
– – ﹤0.01% 1329
2021
Q1 		$358K Buy
4,138
+1,191
+40% +$105K ﹤0.01% 1368
2020
Q4 		$248K Hold
2,947
– – ﹤0.01% 1428
2020
Q3 		$235K Buy
2,947
+282
+11% +$23.4K ﹤0.01% 1351
2020
Q2 		$236K Buy
+2,665
New +$239K ﹤0.01% 1354

Other funds holding UTMD

BIP
Brandes Investment Partners La Jolla, California $14.1B AUM 25.52% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Hotchkis & Wiley Capital Management
Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return
MA
Minerva Advisors Bala Cynwyd, Pennsylvania $155M AUM 35.49% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
RHJA
Rice Hall James & Associates San Diego, California $1.8B AUM 36.16% 1-Year Est. Return

Los Angeles Capital Management's UTMD Position: Q3 2025 in Review

Los Angeles Capital Management sold out of Utah Medical Products (UTMD) in Q3 2025, closing a stake of 11,685 shares — an estimated $665K sold.

Los Angeles Capital Management first reported a position in UTMD in Q2 2020 and held it in 21 quarters. The position peaked at $2.22M in Q2 2024. 117 funds tracked by Wall St. Rank hold UTMD as of Q3 2025.

  • Los Angeles Capital Management reported no remaining Utah Medical Products position as of Q3 2025 after selling out during the quarter.
  • Los Angeles Capital Management sold 11,685 Utah Medical Products shares in Q3 2025, an estimated $665K.
  • Los Angeles Capital Management first reported a position in Utah Medical Products in Q2 2020 and held it in 21 quarters.
  • Los Angeles Capital Management's Utah Medical Products position peaked at $2.22M in Q2 2024.
  • 117 funds tracked by Wall St. Rank held Utah Medical Products as of Q3 2025.

Based on Los Angeles Capital Management's 13F filing for Q3 2025, filed 20 Oct 2025.